Evidence map›Paper›PMID 42438272›Full record

ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026

Association of the CALLY Index With 30-Day Outcomes After Transcatheter Aortic Valve Replacement.

Haitham Abu Khadija, Nizar Abu Hamdeh, Mohammad Masu'd, Duha Najajra, Ameer Mahamid, Max Bagan, Alena Kirzhner, Majde Abu Khaled, Alexander Kogan, Leonid Sternik and 8 more

Abstract read
In one paragraph

Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Haitham Abu KhadijaHeart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel.
Nizar Abu HamdehPalestinian Clinical Research Center, Bethlehem, Palestine.
Mohammad Masu'dPalestinian Clinical Research Center, Bethlehem, Palestine.
Duha NajajraPalestinian Clinical Research Center, Bethlehem, Palestine.
Ameer MahamidHeart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel.
Max BaganAdelson School of Medicine, Ariel University, Ariel, Israel.
Alena KirzhnerDepartment of Internal Medicine A, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Majde Abu KhaledHeart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel.
Alexander KoganDepartment of Cardiac Surgery, The Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, Israel.
Leonid SternikDepartment of Cardiac Surgery, The Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Tel Hashomer, Israel.
Gera GandelmanHeart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel.
Zeina SinnokrotHeart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel.ORCID https://orcid.org/0009-0004-3884-875X
Firas BeshariehHeart Center, Kaplan Medical Center, Rehovot, Affiliated with the Hebrew University, Jerusalem, Israel.
Rashed SaedDepartment of Internal Medicine B, Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Yasmeen AlshamiPalestinian Clinical Research Center, Bethlehem, Palestine.
Nora I BaraghithiPalestinian Clinical Research Center, Bethlehem, Palestine.
Tal SchillerDepartment of Diabetes, Endocrinology and Metabolism, Wolfson Medical Center and Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel.
Mohammad AlneesPalestinian Clinical Research Center, Bethlehem, Palestine.ORCID https://orcid.org/0000-0002-5577-8499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic inflammation and nutritional status influence outcomes after transcatheter aortic valve replacement (TAVR). The C-reactive protein-albumin-lymphocyte (CALLY) index integrates these domains, but its short-term prognostic value and potential nonlinear associations after TAVR remain uncertain.

aimsTo evaluate the association of baseline CALLY with 30-day all-cause mortality, acute kidney injury (AKI), and stroke after TAVR, and to explore potential nonlinear relationships.

methodsWe retrospectively analyzed 816 consecutive TAVR patients stratified into low (n = 272), middle (n = 273), and high (n = 271) CALLY tertiles. Outcomes were defined according to Valve Academic Research Consortium-3 criteria. Cox models estimated crude and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs). Multivariable models were adjusted for age, sex, diabetes, and baseline creatinine. Exploratory piecewise Cox models assessed nonlinearity.

resultsWithin 30 days, 28 patients died (3.4%), 81 developed AKI (9.9%), and 35 experienced stroke (4.3%). Compared with the low tertile, the middle and high tertiles were associated with lower adjusted risks of AKI (middle: HR 0.53, 95% CI 0.31-0.90; p = 0.018; high: HR 0.50, 95% CI 0.29-0.85; p = 0.011). A similar inverse trend was observed for mortality (high vs. low: HR 0.43, 95% CI 0.18-1.06; p = 0.066), although statistical significance was not reached. No significant association was observed for stroke. Piecewise modeling demonstrated a significant overall association between CALLY and AKI (p = 0.043), suggesting a nonlinear threshold-type relationship with higher risk concentrated at lower CALLY values.

conclusionsHigher CALLY values were associated with a lower risk of 30-day AKI after TAVR, with evidence of a nonlinear threshold-type relationship. CALLY may serve as a simple inflammatory-nutritional marker for identifying patients at increased risk of early renal complications.

Indexed as

Aortic Valve StenosisC-Reactive ProteinInflammationInflammation MediatorsNutritional StatusSerum Albumin, HumanTranscatheter Aortic Valve ReplacementAcute Kidney InjuryAgedAged, 80 and overBiomarkersFemaleHumansLymphocyte CountMalePredictive Value of TestsALB protein, humanBiomarkersC-Reactive ProteinInflammation MediatorsSerum Albumin, Human30‐day all‐cause mortalityAKICALLY indexinflammationmalnutritionstroketranscatheter aortic valve replacement (TAVR)

Identifiers

PMID42438272
PMCPMC13532468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.